Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

Interim Package and Resuming Non-COVID Care

Sharing the latest on the interim package and the news from CMS about resuming non-COVID…

read more

Teleheath Toolkit for Providers

The AAOA has developed a telehealth toolkit to help you better understand and apply all the new…

read more

CMS Released More Blanket Waivers

Practitioner Locations CMS is temporarily waiving requirements that out-of-state practitioners be licensed in the state…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

07/15/20: Call for Scientific Papers
Learn more

09/11/20: Membership Application Deadline to be voted in at the 2020 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2020 Annual Meeting Learn more

12/01/20: Research Grant Cycle
Learn more

04/01/21: Fellow Exam Application Deadline
Learn more

06/01/21: Research Grant Cycle
Learn more

06/26/21: Membership Application Deadline to be eligible for AAOA Member rate for the 2021 Basic Course

EDUCATION

On Demand Content!

Register now  for the Core Allergy & Rhinology Concepts: Age of Pandemics and Beyond that is still available on demand! It is a great value for rebooting and training returning or new staff. Core Allergy offers what you need to help refresh or add allergy to your practice — everything from the clinical science to the basics of allergy from a better understanding of testing techniques, vial prep, and dose calculations to other practical implications. Core Rhinology encompassed the highly sought after rhinology content from our former IAR program.  Read More

IFAR

IFAR Impact Factor: 2.454

aaoaf-ifar

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2020 AAOA Annual Meeting
October 24-29, 2020
Virtual || Free For Members
Learn More and Register

AAOA Clinical Insights
Learn More and Register

USP 797 Online Module
Learn More and Register

2021 Basic Course in Allergy & Immunology
July 15-17 | Seattle, WA

News and Updates

We Are Rolling Out Our First Completely Virtual CME Course

Chamberlain’s often-used quote about living in interesting times used to sound trite, but today it…

read more

Resuming SCIT During COVID-19 Pandemic

This summary is intended to provide practicing Otolaryngologists a guide to resuming safe allergy care…

read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PATIENT CORNER

Menu
Nasal Spray

Do I Need an Antihistamine and an Intranasal Steroid?

By James Connolly, MD, FAAOA

Allergic rhinitis is caused by many different antigens. Some  antigen exposure seasonal (limited exposure during the year such as ragweed or tree pollen), and some antigen exposure is year around or perennial, such as dust mites, cat dander, or mold. Each patient also has different levels of severity of their sensitivity or reactions to each antigen. Both factors can affect symptoms and need for additional therapy.

Allergic reactions are made up of two phases: the acute-phase and the delayed-phase inflammation. The acute phase occurs at the site of exposure when the mast cell degranulates, releasing histamines, and causing itching and swelling at the location of exposure. Poison ivy is a good example of acute phase.  Antihistamines work well to block this phase and decrease acute symptoms.

Intranasal steroids are corticosteroids that block the delayed inflammatory phase, inhibiting release of prostaglandins, leukotrienes, and cytokines. These mediators cause a second wave of symptoms and are delivered from immune cells far away from the local exposure site. The majority of symptoms related to allergy (nasal congestion, runny nose, itchy eyes) are a result of this delayed response. The secondary swelling can occur over days and weeks and plays a larger role in repeat exposures.

For patients having mild non-daily reactions from seasonal allergy, antihistamines alone can be all they need. For those patients suffering from daily symptoms and specifically, perennial allergy exposure, intranasal steroids are the most helpful. If nasal steroids alone are not controlling these symptoms, an antihistamine nasal sprays can provide additional control, but oral antihistamines do not offer any additional benefit. 

For those patients with persistent congestion and swelling or underlying asthma, adding an anti-leukotriene, such as montelukast can also be helpful.